In our study, rapamycin showed little effect on the subnetwork of inflammation-related genes, and had no effect on the activation of Jnk, an inflammatory signaling molecule, in the AD model at day 3 of BAPN + AngII challenge. This evidence concerns the gene MAPK8 and Alzheimer disease.